Web6 jun. 2024 · Yumanity and Kineta to host webcast today at 8:30 a.m. EDT. BOSTON, June 06, 2024 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, Inc. (“Yumanity”) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, … Web1 dec. 2024 · Seattle, WA — (December 1, 2024) Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today that the Company will present at the Antibody Engineering and Therapeutics Conference, the Antibody …
Yumanity Therapeutics : VISTA blocking immunotherapy …
WebKineta (Reverse Merger With Yumanity Therapeutics) Cambridge, Massachusetts, United States 51-100 Series B Delisted www.proteostasis.com/ 24,958 Highlights Total Funding Amount $105M Contacts 11 Employee Profiles 11 Investors 8 Similar Companies 235 Find More Contacts for Proteostasis Therapeutics Rick Morimoto Founder Executive … Web21 mei 2024 · to advance optimally engineered allogeneic CRISPR-edited NK cell therapies for the treatment of patients with both hematological malignancies and solid tumors. onktherapeutics.com/intellia-and-o … ford 289 oil pump shaft
Kintara Therapeutics, Inc. (KTRA)
Web10 nov. 2024 · Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc. Web21 apr. 2024 · SEATTLE, April 21, 2024 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense, announced today the formation of a new scientific advisory board (SAB). The SAB will collaborate with members of Kineta's management and … Web18 dec. 2024 · Kineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer … ford 289 oil pump priming tool